AB Science S.A. (EPA:AB)
France · Delayed Price · Currency is EUR 1.338
+0.018 (1.36%)
At close: Feb 20, 2026
AB Science Market Cap
AB Science has a market cap or net worth of €97.6 million as of February 20, 2026. Its market cap has decreased by -5.20% in one year.
Market Cap
97.60M
Enterprise Value
111.65M
Revenue
1.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.34
Market Cap Chart
Since April 26, 2010, AB Science's market cap has decreased from 381.93M to 97.60M, a decrease of -74.44%. That is a compound annual growth rate of -8.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 97.60M | -12.89% |
| Dec 31, 2025 | 112.05M | 94.70% |
| Dec 31, 2024 | 57.55M | -68.19% |
| Dec 29, 2023 | 180.92M | -45.55% |
| Dec 30, 2022 | 332.25M | -40.91% |
| Dec 31, 2021 | 562.31M | -37.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 110.27B |
| Sanofi | 96.10B |
| Sartorius Stedim Biotech | 17.78B |
| Ipsen | 12.95B |
| Innate Pharma | 131.78M |
| ABIONYX Pharma | 118.36M |
| Crossject Société Anonyme | 102.32M |
| OSE Immunotherapeutics | 96.41M |